Drugs / RO5036505
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00967590 | Sep 2009 → Aug 2010 | asthma | Hoffmann-La Roche | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5036505 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00967590 ↗ |
| Route | Intravenous | “380mg iv infusion” NCT00967590 ↗ |